GUO, Hongyan,KIRSCHBERG, Thorstens A.,LIU, Hongtae,LINK, John O.,MITCHELL, Michael L.,PARRISH, Jay P.,SQUIRES, Neil,SUN, Jianyu,BACON, Elizabeth M.,CANALES, Eda,COTTELL, Jeromy J.,DESAI, Manoj C.,HALC
申请号：
MEP19615
公开号：
ME02321B
申请日:
2010.05.12
申请国别(地区):
ME
年份:
2016
代理人:
摘要：
The invention provides a pharmaceutical composition comprising: (1) a compound of the formula: or a pharmaceutically acceptable salt thereof； (2) a NS5B polymerase inhibitor； and (3) a NS3 protease inhibitor； and relates to the use of (1), (2) and (3), in combination, in the prophylactic or therapeutic treatment of hepatitis C or a hepatitis C associated disorder.text
